Elastomeric compositions and their applications

Patent metadata

Field	Value
Publication number	US-12534576-B2
Application number	US-202217718460-A
Country	US
Kind code	B2
Filing date	Apr 12, 2022
Priority date	Jan 28, 2015
Publication date	Jan 27, 2026
Grant date	Jan 27, 2026

Abstract

A condensation curable gel composition is disclosed. The composition comprises: (i) at least one condensation curable silyl terminated polymer having at least one hydrolysable and/or hydroxyl functional group(s) per molecule; (ii) a cross-linker selected from the group of a silicone, an organic polymer, a monosilane or a disilane molecule which contains at least two hydrolysable groups per molecule; and (iii) a condensation catalyst selected from the group of titanates, zirconates or tin (II). The molar ratio of hydroxyl and/or hydrolysable groups in polymer (i) to hydrolysable groups from component (ii) is between 0.5:1 and 1:1 using a monosilane cross-linker or 0.75:1 to 3:1 using disilanes. The titanates and zirconates comprise M-OR functions where M is titanium or zirconium and R is an aliphatic hydrocarbon group. The molar ratio of M-OR or tin (II) functions to the hydroxyl and/or hydrolysable groups in polymer (i) is comprised between 0.01:1 and 0.5:1.

First claim

What is claimed is:

1 . A condensation curable gel composition for making a gel which is the reaction product of the composition, the composition comprising:
(i) at least one condensation curable silyl terminated polymer having at least one hydrolysable and/or hydroxyl functional group(s) per molecule; (ii) a cross-linker selected from the group of a silicone, an organic polymer, a monosilane or a disilane molecule which contains at least two hydrolysable groups per molecule; and (iii) a condensation catalyst selected from the group of titanates or tin (II);
wherein the molar ratio of hydroxyl and/or hydrolysable group(s) in polymer (i) to hydrolysable groups from component (ii) is between 0.5:1 and 1:1 using a monosilane cross-linker or 0.75:1 to 3:1 using disilanes;
wherein the composition is free of zirconate catalysts;
wherein the titanates comprise M-OR functions where M is titanium and R is an aliphatic hydrocarbon group; and
wherein the molar ratio of M-OR or tin (II) functions to the hydroxyl and/or hydrolysable group(s) in polymer (i) is comprised between 0.01:1 and 0.5:1.

2 . The condensation curable gel composition in accordance with claim 1 , wherein the condensation catalyst (iii) is a titanate.

3 . The condensation curable gel composition in accordance with claim 1 , wherein the composition is also free of tin catalysts.

4 . The condensation curable gel composition in accordance with claim 1 , wherein the composition is stored in two parts having:
I) polymer (i) and cross-linker (ii) in one part, and polymer (i) and catalyst (iii) in the other part; or II) cross-linker (ii) in one part, and polymer (i) and catalyst (iii) in the other part; or III) a first polymer (i) and cross-linker (ii) in one part, and a second polymer (i) and catalyst (iii) in the other part.

5 . The condensation curable gel composition in accordance with claim 1 , wherein the molar ratio of M-OR or tin (II) functions to the hydroxyl and/or hydrolysable group(s) in polymer (i) is comprised between 0.02:1 and 0.2:1.

6 . The condensation curable gel composition in accordance with claim 1 , further comprising a polymer curable by hydrosilylation, a hydrosilylation cross-linker, and a hydrosilylation catalyst.

7 . The condensation curable gel composition in accordance with claim 1 , wherein the cross-linker (ii) is further defined as (ii) a silane cross-linker, and wherein the silane cross-linker (ii) comprises the monosilane, the disilane molecule, or a combination thereof.

8 . The condensation curable gel composition in accordance with claim 7 , wherein the silane cross-linker (ii) comprises, or optionally is, the monosilane.

9 . The condensation curable gel composition in accordance with claim 8 , wherein the molar ratio of hydroxyl and/or hydrolysable group(s) in polymer (i) to hydrolysable groups from component (ii) is between 0.5:1 and 0.75:1.

10 . The condensation curable gel composition in accordance with claim 7 , wherein the silane cross-linker (ii) comprises, or optionally is, the disilane molecule.

11 . The condensation curable gel composition in accordance with claim 10 , wherein the molar ratio of hydroxyl and/or hydrolysable group(s) in polymer (i) to hydrolysable groups from component (ii) is between 0.75:1 to 1.5:1.

12 . The condensation curable gel composition in accordance with claim 1 , wherein:
i) the polymer (i) has at least two hydrolysable and/or hydroxyl functional groups per molecule; ii) the cross-linker (ii) contains at least three hydrolysable groups per molecule; or iii) both i) and ii).

13 . A coating formed from the condensation curable gel composition in accordance with claim 1 , wherein the coating is formed following application of the composition to a substrate, optionally wherein the coating is applied using a dispenser selected from curtain coaters, spray devices, die coaters, dip coaters, extrusion coaters, knife coaters, and screen coaters.

14 . A gel which is the condensation reaction product of the condensation curable gel composition in accordance with claim 1 .

15 . A method of making the gel in accordance with claim 14 , wherein the composition is stored in two parts, provided the cross-linker (ii) is in one part, the catalyst (iii) is in the other part, and the polymer (i) is in either or both parts, and wherein the two parts of the composition are intermixed and cured.

16 . An encapsulant or a pottant for electronic devices, solar photovoltaic modules, and/or light emitting diodes, wherein the encapsulant or pottant comprises the gel in accordance with claim 14 .

17 . An implant, a shoe sole, or a self-sealing anti-puncture coating for tyres, wherein the implant, shoe sole, or coating comprises the gel in accordance with claim 14 .

18 . A pressure sensitive adhesive comprising the gel in accordance with claim 14 .

19 . A lamination process to laminate substrates together comprising laminating at least one substrate to another substrate with the gel in accordance with claim 14 .

20 . A medical application comprising the gel in accordance with claim 14 , optionally wherein the gel is for drug delivery, the gel is for wound care, a soft skin adhesive comprises the gel, a transdermal patch comprises the gel, and/or the gel is for the controlled release of medicaments.

Assignees

• Dow Silicones Corp

Inventors

• Gubbels Frederic
• TEIXEIRA de CARVALHO Sandrine

Classifications

• H10H20/854

  characterised by their material, e.g. epoxy or silicone resins · CPC title

• H10F19/804

  Materials of encapsulations · CPC title

• H01L2924/0002

  Electricity · mapped topic

• C08G77/18

  to alkoxy or aryloxy groups · CPC title

• H01L23/296

  Electricity · mapped topic